Compare Becton Dickinson and Co (BDX) vs FedEx Corporation (FDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs FedEx Corporation — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while FedEx Corporation trades at $322.43 (market cap $75.37B). The key difference: FedEx Corporation is the larger of the two by market cap, and Becton Dickinson and Co pays the higher dividend (2.34%). Which is the better fit depends on your goals.
| BDX | FDX | |
|---|---|---|
Market Cap | $48.93B | $75.37B |
Sector | Health | Industrials |
52-Week High | $185.39 | $338.75 |
52-Week Low | $138.62 | $180.51 |
Enterprise Value | $65.03B | $105.00B |
Dividend Yield | 2.34% | 1.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
FedEx (FDX) trades at $318.57, up 0.85% with a bullish technical signal despite mixed moving averages. The company shows solid fundamentals with a P/E of 17.17 and net income margin of 4.68%, supported by recent earnings beats. Network transformation initiatives and premium revenue mix are driving operational improvements, while analyst consensus remains strongly positive with a $360.27 price target.
Outlook remains favorable with projected revenue growth to $94.7B in 2026 and continued margin expansion. Key risks include competitive pressures in logistics and macroeconomic sensitivity. The stock offers value with reasonable valuation metrics and strong institutional support, though investors should monitor execution of cost-saving initiatives and freight demand trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →
